ONC debuts ONC Tech Lab to focus its standards & technology work

The Office of the National Coordinator for Health IT (ONC) introduced the ONC Tech Lab which “represents the way in which we will organize and approach the type of work we do,” according to a blog post written by Steven Posnack, MS, MHS, director of ONC’s Office of Standards and Technology.

Citing efforts to advance interoperability, Posnack said the lab will help ensure that the agency’s work will be connected and aligned to those efforts.

“In concert with the ONC Health IT Certification Program, we believe this principled approach will provide internal and external stakeholders with common connection points to ONC’s standards and technology efforts,” he wrote. “This transition lays the operational groundwork within ONC necessary to implement the Interoperability Roadmap and ties directly to our near-term health IT strategy and, ultimately, the long-term vision included in the Federal Health IT Strategic Plan.”

ONC plans to use the ONC Tech Lab’s organizing structure to help focus on contributions to improve existing standards and build consensus around those that best serve specific interoperability needs.

ONC will work directly with standards development organizations through their processes, partnering with stakeholders industry-wide to shorten feedback loops and pilot testing to gain evidence about what can scale. “In the end, we want to see standards in use that have been rigorously tested and consistently implemented.”

The ONC Tech Lab will be organized around and focus on the following four areas: standards coordination; texting and utilities; pilots; and innovation.

ONC will publish four more blog posts detailing the work lined up in each of these focus areas.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.